HomeTYRA • NASDAQ
add
Tyra Biosciences Inc
Previous close
$15.97
Day range
$14.55 - $15.71
Year range
$12.17 - $29.60
Market cap
769.17M USD
Avg Volume
214.66K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 28.60M | 19.37% |
Net income | -24.02M | -13.54% |
Net profit margin | — | — |
Earnings per share | -0.41 | 16.33% |
EBITDA | -28.48M | -19.25% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 360.13M | 67.00% |
Total assets | 380.59M | 59.67% |
Total liabilities | 18.30M | 13.07% |
Total equity | 362.29M | — |
Shares outstanding | 52.87M | — |
Price to book | 2.33 | — |
Return on assets | -18.50% | — |
Return on capital | -19.04% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -24.02M | -13.54% |
Cash from operations | -17.90M | -4.39% |
Cash from investing | 21.56M | 26,072.29% |
Cash from financing | 743.00K | 59.10% |
Net change in cash | 4.40M | 126.26% |
Free cash flow | -8.96M | -37.65% |
About
Founded
2018
Headquarters
Website
Employees
49
